Kumar, Sanjeev <br/><br/>
Metabolism and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in humans.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Mar 2010 
 - 474-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1521-009X 
<br/><br/><label>Standard No.: </label>10.1124/dmd.109.028704  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anticholesteremic Agents--adverse effects<br/>Biotransformation<br/>Cholesterol Ester Transfer Proteins--antagonists & inhibitors<br/>Cytochrome P-450 CYP3A--genetics<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--genetics<br/>Feces--chemistry<br/>Humans<br/>Isoenzymes--antagonists & inhibitors<br/>Male<br/>Microsomes, Liver--enzymology<br/>Middle Aged<br/>Molecular Structure<br/>Oxazolidinones--adverse effects<br/>Recombinant Proteins--antagonists & inhibitors<br/>Tandem Mass Spectrometry<br/>Young Adult